Mankind Pharma Limited (MANKIND.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 827.82B |
| Enterprise Value | 886.11B |
| P/E Ratio | 51.22 |
| PEG Ratio | 8.54 |
| Price/Sales Ratio | 7.1 |
| Price/Book Ratio | 6.32 |
| Enterprise/Revenue | 7.1 |
| Enterprise/EBITDA | 25.97 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 142.78B |
| Revenue/Share | 356.99 |
| Gross Profit | 61.55B |
| EBITDA | 38.58B |
| Net Income | 19.13B |
| Diluted EPS | 46.28 |
Balance Sheet
| Total Cash | 22.08B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 401.16 |
Price History
| 52-Week Change | 3.91 |
| 52-Week High | 2,642 |
| 52-Week Low | 1,909.7 |
| Moving Average 50 Days | 2,413.06 |
| Moving Average 200 Days | 2,292.98 |
Statistics
| Average Volume | 429,646 |
| Shares Outstanding | 413M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.02 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
